tradingkey.logo

Lilly's Ebglyss Single Monthly Maintenance Injection Achieved Completely Clear Skin At Three Years In Half Of Patients With Moderate-To-Severe Atopic Dermatitis

ReutersMar 7, 2025 2:02 PM

- Eli Lilly and Co LLY.N:

  • LILLY'S EBGLYSS® (LEBRIKIZUMAB-LBKZ) SINGLE MONTHLY MAINTENANCE INJECTION ACHIEVED COMPLETELY CLEAR SKIN AT THREE YEARS IN HALF OF PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI